BostonGene Stock

HealthTech

BostonGene develops biomedical software for advanced patient analysis and personalized therapy. Their platform utilizes artificial intelligence for molecular genetic and immune profiling, decoding cancer patients' molecular profiles, including the immune system and tumor microenvironment. This approach uncovers key disease drivers, identifies novel drug targets, and recommends effective treatments. By providing precise, clinically validated insights, BostonGene enables clinicians to drive precision medicine and advance oncology research.